Responsive risk assessment tool for drug criticality and vulnerability for Health Canada

Health Canada has a requirement for access to information products to support the determination of shortage risk for drugs and the maintenance CVDL. We require that these information products provide us data and risk assessments showing the likelihood that a shortage of a drug would cause harm (criticality) and the likelihood of a drug going into shortage (vulnerability). The data must be on a web platform that can be accessed by Health Canada employees.